Literature DB >> 26355422

Ebola Virus Disease--Sierra Leone and Guinea, August 2015.

Sara Hersey, Lise D Martel, Amara Jambai, Sakoba Keita, Zabulon Yoti, Erika Meyer, Sara Seeman, Sarah Bennett, Jeffrey Ratto, Oliver Morgan, Mame Afua Akyeampong, Schabbethai Sainvil, Mary Claire Worrell, David Fitter, Kathryn E Arnold.   

Abstract

The Ebola virus disease (Ebola) outbreak in West Africa began in late 2013 in Guinea (1) and spread unchecked during early 2014. By mid-2014, it had become the first Ebola epidemic ever documented. Transmission was occurring in multiple districts of Guinea, Liberia, and Sierra Leone, and for the first time, in capital cities (2). On August 8, 2014, the World Health Organization (WHO) declared the outbreak to be a Public Health Emergency of International Concern (3). Ministries of Health, with assistance from multinational collaborators, have reduced Ebola transmission, and the number of cases is now declining. While Liberia has not reported a case since July 12, 2015, transmission has continued in Guinea and Sierra Leone, although the numbers of cases reported are at the lowest point in a year. In August 2015, Guinea and Sierra Leone reported 10 and four confirmed cases, respectively, compared with a peak of 526 (Guinea) and 1,997 (Sierra Leone) in November 2014. This report details the current situation in Guinea and Sierra Leone, outlines strategies to interrupt transmission, and highlights the need to maintain public health response capacity and vigilance for new cases at this critical time to end the outbreak.

Entities:  

Mesh:

Year:  2015        PMID: 26355422     DOI: 10.15585/mmwr.mm6435a6

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  6 in total

1.  Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

Authors:  Lihua Wu; Zhe Zhang; Hainv Gao; Yuhua Li; Lihua Hou; Hangping Yao; Shipo Wu; Jian Liu; Ling Wang; You Zhai; Huilin Ou; Meihua Lin; Xiaoxin Wu; Jingjing Liu; Guanjing Lang; Qian Xin; Guolan Wu; Li Luo; Pei Liu; Jianzhong Shentu; Nanping Wu; Jifang Sheng; Yunqing Qiu; Wei Chen; Lanjuan Li
Journal:  Hum Vaccin Immunother       Date:  2017-07-14       Impact factor: 3.452

2.  Cryo-EM structure of the Ebola virus nucleoprotein-RNA complex.

Authors:  Robert N Kirchdoerfer; Erica Ollmann Saphire; Andrew B Ward
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-04-24       Impact factor: 1.056

Review 3.  Misconceptions and Rumors about Ebola Virus Disease in Sub-Saharan Africa: A Systematic Review.

Authors:  Basilua Andre Muzembo; Ngangu Patrick Ntontolo; Nlandu Roger Ngatu; Januka Khatiwada; Tomoko Suzuki; Koji Wada; Kei Kitahara; Shunya Ikeda; Shin-Ichi Miyoshi
Journal:  Int J Environ Res Public Health       Date:  2022-04-13       Impact factor: 4.614

4.  Novel Use of Flu Surveillance Data: Evaluating Potential of Sentinel Populations for Early Detection of Influenza Outbreaks.

Authors:  Ashlynn R Daughton; Nileena Velappan; Esteban Abeyta; Reid Priedhorsky; Alina Deshpande
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

5.  Managing emerging transnational public health security threats: lessons learned from the 2014 West African Ebola outbreak.

Authors:  Aaron M Wendelboe; Micah McCumber; Julie Erb-Alvarez; Nicholas Mould; Richard W Childs; James L Regens
Journal:  Global Health       Date:  2018-07-27       Impact factor: 4.185

6.  Reporting quality of the 2014 Ebola outbreak in Africa: A systematic analysis.

Authors:  Nina Huynh; Andrea Baumann; Mark Loeb
Journal:  PLoS One       Date:  2019-06-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.